MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Immunovant, Inc. (IMVT)
Immunovant, Inc. (IMVT)
source: myfinsight.com
Download
Download image
Net loss
-$505,606K
Loss before
provision for income taxes
-$505,391K
Provision for income taxes
$215K
Interest income, net
$25,330K
Other (income)
expense, net
$2,181K
Total operating
expenses
$532,902K
Research and development
$456,660K
General and
administrative
$76,242K
Back